0 Comments
0 Shares
185 Views
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
GLP-1 Receptor Agonist Market Expansion Through Pharmaceutical R&D InvestmentsThe global GLP-1 Receptor Agonist Market was valued at USD 66.4 billion in 2025 and is projected to grow from USD 82.0 billion in 2026 to USD 185.3 billion by 2033, registering a CAGR of 12.4% from 2026 to 2033. The market is witnessing remarkable growth due to the rising prevalence of type 2 diabetes, obesity, and other metabolic disorders, coupled with increasing clinical acceptance...0 Comments 0 Shares 335 Views
-
Global Dual GIP/GLP-1 Receptor Agonists Obesity Drugs Market: Manufacturers, Market Size and Growth Opportunities"According to the latest report published by Data Bridge Market Research, the Dual GIP/ GLP-1 Receptor Agonists Obesity Drugs Market CAGR Value The global dual GIP/ GLP-1 receptor agonists obesity drugs market size was valued at USD 4.75 billion in 2024 and is expected to reach USD 17.71 billion by 2032, at a CAGR of 17.85% during the forecast period This world-wide...0 Comments 0 Shares 86 Views
-
GLP-1 Analogue Market - Endocrinology Integration and Metabolic Disease CoordinationMarket Overview Endocrinology integration and metabolic disease coordination represent essential capabilities advancing GLP-1 therapy through endocrinology specialist networks, multidisciplinary coordination, and comprehensive programs enabling systematic therapy access and optimized metabolic disease management outcomes. The GLP-1 Analogue Market transformation toward integration...0 Comments 0 Shares 66 Views
-
GLP-1 Drug Market – Diabetes and Obesity Demand Reshape Metabolic CareThe GLP-1 drug market is expanding rapidly as diabetes and obesity create sustained demand for therapies that support glycemic management and weight-related care. The market was valued at USD 10.77 billion in 2024, is estimated at USD 12.19 billion in 2025, and is projected to reach USD 42 billion by 2035, growing at a CAGR of 13.17%.marketresearchfuture GLP-1 therapies are increasingly...0 Comments 0 Shares 100 Views
-
GLP-1 Drug Market Forecast: Future Potential in Metabolic Disease ManagementThe GLP-1 Drug Market forecast suggests strong expansion as healthcare providers continue to prioritize advanced treatments for metabolic disorders. The increasing prevalence of type 2 diabetes across both developed and emerging economies is one of the primary drivers supporting the adoption of GLP-1 receptor agonists. These medications not only improve blood sugar control but also help reduce...0 Comments 0 Shares 239 Views
-
GLP-1 Drug Market: Expanding Role in Metabolic HealthGLP-1 Drug Market: Expanding Role in Metabolic Health Market Overview and Growth Snapshot The GLP-1 Drug Market has gained significant traction as metabolic health becomes a global priority. These drugs are widely used for managing blood sugar levels and supporting weight loss, making them essential in treating metabolic disorders. The market has grown rapidly due to increasing...0 Comments 0 Shares 225 Views
-
GLP-1 Market Forecast: Innovation and Broader Therapeutic Use Support 10.9% CAGRGLP-1 Market to Reach USD 133.92 Billion by 2034, Growing at 10.9% CAGR: Polaris Market Research According to Polaris Market Research, the global GLP-1 market was valued at USD 52.82 billion in 2025 and is projected to reach USD 133.92 billion by 2034. The market is estimated at USD 58.48 billion in 2026 and is expected to grow at a CAGR of 10.9% during 2026–2034. Expansion is being...0 Comments 0 Shares 69 Views
-
GLP-1 Market: Drivers, Challenges, and Future ProspectsThe GLP-1 Market is expanding as therapeutic applications move beyond diabetes into obesity and cardiovascular disease. Valued at USD 52.82 billion in 2025, the GLP-1 Market is projected to reach USD 58.48 billion in 2026 and USD 133.92 billion by 2034, growing at a CAGR of 10.9% during the forecast period 2026–2034. Key players include AstraZeneca, Boehringer Ingelheim, D&D...0 Comments 0 Shares 151 Views
-
GLP-1 Receptor Agonist Market Heads Toward USD 7.9 Billion by 2036, India - CAGR 8.4%, China - CAGR 7.1%, Germany - CAGR 6.6%The global GLP-1 receptor agonist market growing from USD 3 billion in 2026 to USD 7.9 billion by 2036, expanding at a CAGR of 11.7% during the forecast period. The market is gaining momentum as type 2 diabetes and obesity become more widespread, while GLP-1 therapies offer combined benefits for blood sugar management, appetite reduction, and weight control. The market is expected to add USD...0 Comments 0 Shares 74 Views
-
GLP-1-Based Nutrition Market Share and Future Outlook By FMINEWARK, Del., USA | May 13, 2026 — According to Future Market Insights (FMI), the global GLP-1 meal replacement market is witnessing rapid expansion, driven by growing adoption of GLP-1 medications, rising consumer preference for nutrient-dense meal formats, and increasing demand for convenient nutrition solutions tailored to reduced-appetite lifestyles. The market is also benefiting from...0 Comments 0 Shares 185 Views
-
How Rising Demand for Weight Management Treatments Is Influencing the GLP-1 Analogues MarketDemographic Drivers The GLP-1 analogues market, valued at USD 56.62 billion in 2025 and projected to grow at a CAGR of 21.39% from 2026 to 2034, is supported by expanded regulatory approvals for chronic weight management and cardiovascular risk reduction. Demographics add to this momentum. The geriatric population is at higher risk of diabetes and related conditions, and the report cites the...0 Comments 0 Shares 75 Views
-
Global GLP-1 Agonists Weight Loss Drugs Industry ReportThe global GLP-1 Agonists Weight Loss Drugs Market was valued at USD 13.8 billion in 2024 and is projected to grow from USD 27.5 billion in 2026 to USD 48.8 billion by 2030, registering a CAGR of 18.5% from 2025 to 2030. North America dominated the market with a 75.5% revenue share in 2024, supported by high obesity prevalence, favorable reimbursement policies, strong pharmaceutical...0 Comments 0 Shares 268 Views
-
Pen Needles Market Growth Supported by Aging PopulationsThe pen needles market is increasingly being shaped by a simple healthcare priority: making injectable therapies easier and more comfortable to manage. As diabetes prevalence continues to rise and more patients administer medications at home, Pen Needles Market are becoming an important part of everyday disease management. The global market was valued at USD 4.8 billion in 2025 and is projected...0 Comments 0 Shares 147 Views
More Results
Bangla